# Safety and Pharmacokinetics of Probucol and Cilostazol

> **NCT00549978** · PHASE4 · COMPLETED · sponsor: **Korea Otsuka Pharmaceutical Co., Ltd.** · enrollment: 32 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Cilostazol
- **DRUG:** Probucol

## Key facts

- **NCT ID:** NCT00549978
- **Lead sponsor:** Korea Otsuka Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2008-05
- **Final completion:** 2008-08
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2022-03-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00549978

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00549978, "Safety and Pharmacokinetics of Probucol and Cilostazol". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00549978. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*